Category Archives: Healthcare

Ascendis Pharma (ASND) Gets a Buy Rating from Cantor Fitzgerald

In a report released today, Alethia Young from Cantor Fitzgerald maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with a price target of $185. The company’s shares opened today at $128.34, close to its 52-week high of

Cantor Fitzgerald Sticks to Its Buy Rating for Amarin (AMRN)

Cantor Fitzgerald analyst Louise Chen maintained a Buy rating on Amarin (AMRN – Research Report) today and set a price target of $35. The company’s shares opened today at $21.23, close to its 52-week high of $23.34. Chen commented: “We

Northland Securities Remains a Hold on Irhythm Technologies (IRTC)

In a report released today, Suraj Kalia from Northland Securities maintained a Hold rating on Irhythm Technologies (IRTC – Research Report), with a price target of $75. The company’s shares opened today at $91.04. According to TipRanks.com, Kalia is a

Medtronic (MDT) Gets a Hold Rating from Northland Securities

Northland Securities analyst Suraj Kalia maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $84. The company’s shares opened today at $93.26. Kalia said: “We highlight these results vis-a-vis Edwards’ PARTNER-3 Study

Cantor Fitzgerald Believes GW Pharma (NASDAQ: GWPH) Still Has Room to Grow

In a report released today, Elemer Piros from Cantor Fitzgerald reiterated a Buy rating on GW Pharma (GWPH – Research Report), with a price target of $196. The company’s shares closed on Friday at $169.32, close to its 52-week high

Analysts Offer Insights on Healthcare Companies: Helius Medical Technologies (NASDAQ: HSDT), Progenics (NASDAQ: PGNX) and Dermira (NASDAQ: DERM)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Helius Medical Technologies (HSDT – Research Report), Progenics (PGNX – Research Report) and Dermira (DERM – Research Report) with bullish sentiments. Helius